Socialiya - Entertainment. Knowledge. Community.
ASCO 2026: GLP-1s could reduce the risk of some obesity-related cancers progressing

Real-world data from 12112 patients demonstrates that GLP-1 receptor agonists may significantly redu...

HEALTH NEWS May 21, 2026

ASCO 2026: GLP-1s could reduce the risk of some obesity-related cancers progressing

Real-world data from 12112 patients demonstrates that GLP-1 receptor agonists may significantly reduce metastatic progression in four obesity-related...

4 views 0 likes 0 comments
Share:
Real-world data from 12112 patients demonstrates that GLP-1 receptor agonists may significantly reduce metastatic progression in four obesity-related...

Author: Oncology Central

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya